For the 2025 outlook, Novo Nordisk now expects 13-21% revenue increase at constant exchange rates (CER). Operating profit is ...

IT ONCE boasted over five million subscribers and saw one million of us stepping onto the scales every year. But Weight ...

Wegovy and Mounjaro have been taking the world by storm for their unprecedented ability to help people shed weight. New ...

A leading obesity doctor has said a new trial of weight loss drugs Mounjaro and Wegovy may lead advertisers to reconsider their prices.

Two blockbuster weight-loss drugs just went head-to-head — and the results are stunning. In a major new trial, Mounjaro ...

Tirzepatide is a weight loss drug for adults with obesity or with overweight who also have weight-related medical problems, as Zepbound in the US and Mounjaro in some countries outside of the US ...

In a nutshell Tirzepatide (Mounjaro) produced 20.2% weight loss compared to semaglutide’s (Wegovy) 13.7% after 72 weeks of ...

Both medications were prescribed as weekly injections for patients clinically classified as obese, and were recommended ...

Weight loss drugs and jabs have become more popular and a recent study looked at the effectiveness of two drugs ...

President Donald Trump signed an executive order on Monday aimed at slashing prescription drug prices in the U.S. that could ...

The findings come after reports of nasty side effects - including eye problems, infections and gastrointestinal disorders - ...

The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the ...